This Organisation is not specific to Greece. For more details, please visit OpenAIRE Explore.

arrow_backBack to results page

downloadDownload

Powered by OpenAIRE Graph

Last update of records in OpenAIRE: Oct 18, 2026

Found an issue? Give us feedback

corporate_fareOrganisation

APEPTICO

APEPTICO FORSCHUNG UND ENTWICKLUNG GMBH

Organisation website

Location

location_onAustria

Identifiers

Projects(1)

assignment_turned_inProjectOpen Access Mandate for Publications
Exploration of safety, tolerability and clinical efficacy of Solnatide IMP in patients infected with the 2019 new coronavirus (Solnatide)
Completed
Apr 2020 - Jun 2022
European CommissionH2020Overall Budget: €1,626,020.00 Funder contribution: €1,626,020.00 Grant: H2020-SC1-PHE-CORONAVIRUS-2020-101003595
Advancing knowledge for the clinical and public health response to the 2019-nCoV epidemicAdvancing knowledge for the clinical and public health response to the 2019-nCoV epidemicAdvancing knowledge for the clinical and public health response to the 2019-nCoV epidemic
Partners: APEPTICO BCN PEPTIDES LMU OPIS SRL RTDS Association (RTDS)
location_on Austria Spain Germany Italy
DOI: 10.3030/101003595

Data sources

Recent Publications

Recent Research data

Recent Research software

Recent Other research products

Parent Organisations

N/A

Child Organisations

N/A

Versions (1)

corporate_fareOrganisation
APEPTICO(APEPTICO FORSCHUNG UND ENTWICKLUNG GMBH)

Research Footprint

Total research products

Research products

Openness

Last 5 Years

Fields of Science

SDGs

Data Sources

Projects

Total research products 1

European Commission1